PG vs TRDA · P/E 25, rev $84.28B vs P/E 12, rev $210.8M
Procter & Gamble Company (PG) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
PG currently screens at market cap $373.53B and trailing P/E 25.3. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the PG and TRDA stock pages for the full models.
Not investment advice.